Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06053294
Other study ID # 19-927
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2023
Est. completion date May 1, 2029

Study information

Verified date May 2024
Source Virginia Polytechnic Institute and State University
Contact Alexandra G DiFeliceantonio, PhD
Phone 5405262285
Email dife@vt.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Dietary factors contributed to nearly 50% of all cardiometabolic deaths in the US in 2012, making it one of the leading causes of preventable death in the US, second only to tobacco use. Human diets and food choices can't help but be influenced by the ubiquitous availability of processed foods of high-energy density and low nutrient content, consumption of which can lead to obesity, type II diabetes, heart disease, and other types of metabolic dysfunction. Surprisingly, food reinforcement does not rely on perceived energy density. Rather food reinforcement is associated with actual energy density and therefore, on an implicit knowledge of caloric content. That implicit knowledge must have a neural signature and a mechanism by which the gut communicates nutritive value to the brain. There is evidence, at least for fat and carbohydrates, that these pathways are separable, but terminate in a common neural structure, the dorsal striatum or caudate. This could be one mechanism by which modern processed foods high in both fat and carbohydrate are so sought after and readily consumed, In fact, when experimentally tested, fat and carbohydrate combinations were more reinforcing calorie for calorie than fat or carbohydrates alone and the level of reinforcement correlated with activity in reward- related brain areas. Beyond simple reinforcing value, it is known from the literature on drugs of abuse that the faster a drug is arrives at the brain, the higher it's abuse potential, however, little is known about how the kinetics of nutrient excursion influence food preference, choice, and brain activity. This project aims to test this specifically for carbohydrate reward.


Recruitment information / eligibility

Status Recruiting
Enrollment 64
Est. completion date May 1, 2029
Est. primary completion date May 1, 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: 1. BMI between 18.5-30 kg/m2 2. Not pregnant or planning to become pregnant during study participation 3. Residing in the Roanoke area and/or willing/able to attend sessions at the Fralin Biomedical Research Institute 4. Able to speak and write in English Exclusion Criteria: 1. Current inhaled nicotine use 2. History of alcohol dependence. 3. Current or past diagnosis of diabetes or thyroid problems. 4. Taking medications known to influence study measures (including antiglycemic agents, thyroid medications, sleep medications) 5. Active medical or neurologic disorder. 6. Current shift work (typical pattern of work/activity overnight) 7. Previous weight loss surgery 8. Adherence to a special diet within the past 3 months (e.g., low-carb or ketogenic diet, exclusion of food groups/specific macronutrients, intermittent fasting, etc.) 9. Allergy to any food or ingredient included in the study diets, meals, or beverages 10. Currently pregnant or planning to become pregnant during study participation 11. Claustrophobia 12. Contraindications for MRI, including pacemaker, aneurysm clips, neurostimulators, cochlear or other implants, metal in eyes, regular work with steel, etc.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
CS- Beverage
Conditioned Stimulus - (CS-): Flavored beverage solution with sweetness-matched sucralose. Participants will consume flavored beverage solutions sweetened with sucralose to match the sweetness of 110 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws and indirect calorimetry measurement over a 2-hour period. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.
CS+Fast
(CS+): Flavored beverage solution with 110 calories of sucrose. Participants will consume flavored beverage solutions containing 110 calories of sucrose in 6 exposure sessions within 1 week. One exposure session will include pre- and post-consumption blood draws and indirect calorimetry measurement over a 2-hour period. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.
CS+Slow
(CS+): Flavored beverage solution with 110 calories of maltodextrin. Participants will consume flavored beverage solutions containing 110 calories of maltodexrin in 6 exposure sessions within 1 week.One exposure session will include pre- and post-consumption blood draws and indirect calorimetry measurement over a 2-hour period. The other 4 exposure sessions will occur at specified times outside the laboratory sessions. Subjective ratings of internal state (i.e., hunger, fullness, and thirst) will be collected throughout each exposure. Subjective ratings of liking and wanting of each beverage will also be assessed.

Locations

Country Name City State
United States Fralin Biomedical Research Institute at VTC Roanoke Virginia

Sponsors (1)

Lead Sponsor Collaborator
Virginia Polytechnic Institute and State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in preference- liking Subjective ratings of liking of flavors used in the intervention will be assessed at baseline and after the intervention.
The generalized Labeled Magnitude Scale will be used. The scale is anchored by descriptors of "Most Disliked Sensation Imaginable" and "Most Liked Sensation Imaginable" at the lower and upper ends, respectively. The score is determined by the place on the scale participants select (range of scale is 0-100). An increase in score from baseline to post-intervention indicates an increase in liking.
at the end of the study; 5 weeks after start of study
Secondary Change in preference- wanting, rated Subjective ratings of wanting of flavors used in the intervention will be assessed at baseline and after the intervention. A Visual Analog Scale will be used. Participants select a place on the line that corresponds with their subjective rating, and the score is determined by the place selected (range of scores is 0-100). The line is anchored by polar opposite descriptors ("Do not want at all" and "Want very much"). An increase in score from baseline to post-intervention indicates and increase in wanting. at the end of the study; 5 weeks after start of study
Secondary Change in preference- wanting, ad lib intake Ad libitum intake will be used as a measure of wanting in a post-test session. Participants will be provided each beverage used during the intervention and asked to drink as much or as little of them as they would like over a 30- minute period. at the end of the study; 5 weeks after start of study
Secondary Change in preference- wanting, forced choice Forced choice will be used as a measure of wanting in a post-test session. Participants will be provided each of the beverages used during the intervention and asked to choose 1 to take home with them. at the end of the study; 5 weeks after start of study
Secondary Blood oxygen level-dependent (BOLD) response to beverages In a post-test session, functional magnetic resonance imaging (fMRI) scans will be performed while beverages (without calories) used during the intervention are delivered through a custom manifold fitted to a head coil and connected to a pump system that allows precisely timed and measured delivery of liquids. at the end of the study; 5 weeks after start of study
Secondary Blood glucose response to beverages Blood glucose will be assessed at baseline and at set time points for 1 hour after consumption of intervention beverages in one exposure session. Each week for 3 weeks during the study
Secondary Blood insulin response to beverages Blood insulin will be assessed at baseline and at set time points for 2 hours after consumption of intervention beverages in an exposure session. Each week for 3 weeks during the study
Secondary Energy expenditure in response to beverages Indirect calorimetry will be used to determine energy expenditure at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session. Each week for 3 weeks during the study
Secondary Respiratory exchange ratio in response to beverages Indirect calorimetry will be used to determine respiratory exchange ratio at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session. Each week for 3 weeks during the study
Secondary Substrate oxidation in response to beverages Indirect calorimetry will be used to determine substrate oxidation at baseline (for 30 minutes) and for 1 hour after consumption of intervention beverages in an exposure session. Each week for 3 weeks during the study
See also
  Status Clinical Trial Phase
Recruiting NCT03682861 - Effect of Glycogen Replenishment on Time Trial Performance Following a Glycogen Lowering Exercise N/A
Completed NCT04629742 - Low Sodium Neapolitan Pizza Prepared With Seawater: Nutritional Properties, Sensory Characteristics, Metabolic Effects N/A
Completed NCT03185884 - Carbohydrates and Children N/A
Completed NCT06400836 - Nutrient Timing in Connection to Evening Exercise N/A
Withdrawn NCT03436875 - Cardiometabolic and Mental Health in the RGV
Completed NCT02068638 - Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes N/A